Skip to main content

Advertisement

Log in

Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review

  • Review Article
  • Published:
Oral and Maxillofacial Surgery Aims and scope Submit manuscript

Abstract

Purpose

Surgical management of bisphosphonate-related osteonecrosis of the jaws (BRONJ) has been performed in an attempt to increase healing rates of the affected cases. This literature review aimed to identify clinical studies of surgical management of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in order to assess their surgical treatment modalities, outcome and the follow-up.

Methods

A search in the PubMed (Medline) database using specific terms and/or phrases as “bisphosphonate-related osteonecrosis” or “jaw osteonecrosis”, and “surgical treatment” or “surgical management” was conducted in order to identify clinical trials and cases of surgical treatment of BRONJ. The review search covered the time period from 2004 to 2014. All studies identified in the search were selected according to the inclusion criteria. Relevant information was recorded according to the following items: author, year, number of patients, BRONJ clinical stage, surgical treatment modality, clinical success, and follow-up.

Results

The initial database search yielded 345 titles. After filtering, 67 abstracts were selected culminating in 67 full text articles. A variety of surgical approach was found in this review: debridement, sequestrectomy bone resection, and bone reconstruction. Adjunctive therapies included hyperbaric oxygen, laser therapy, growth factors, and ozone.

Conclusion

Although there are many indexed studies about BRONJ, well-documented reports concerning surgical therapeutically techniques are scarce, resulting from a lack of well-established protocols. Considerable differences were found regarding sample size, surgical treatment modalities and outcomes. Clinical studies with larger number of patients and longer follow-up are required to provide best information for each surgical treatment modality and its outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Russell RG (2011) Bisphosphonates: the first 40 years. Bone 49(1):2–19

    Article  CAS  PubMed  Google Scholar 

  2. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) American association of oral and maxillofacial surgeons. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72(10):1938–1956

    Article  PubMed  Google Scholar 

  3. Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83(9):1032–1045

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Dominguez LJ, Di Bella G, Belvedere M, Barbagallo M (2011) Physiology of the aging bone and mechanisms of action of bisphosphonates. Biogerontology 12(5):397–08

    Article  CAS  PubMed  Google Scholar 

  5. Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA et al (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209–257

    Article  CAS  PubMed  Google Scholar 

  6. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369

    Article  Google Scholar 

  7. Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433

    Article  PubMed  Google Scholar 

  8. Ruggiero SL (2011) Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci 1218:38–46

    Article  CAS  PubMed  Google Scholar 

  9. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis: an American academy of oral medicine position paper. J Am Dent Assoc 136(12):1658–1668

    Article  CAS  PubMed  Google Scholar 

  10. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaw—2009 update. Aust Endod J 35(3):119–130

    Article  PubMed  Google Scholar 

  11. Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65(3):415–423

    Article  PubMed  Google Scholar 

  12. Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67(5 Suppl):61–70

    Article  PubMed  Google Scholar 

  13. Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63(11):1567–1575

    Article  PubMed  Google Scholar 

  14. Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41(3):318–320

    Article  CAS  PubMed  Google Scholar 

  15. Bagán J, Blade J, Cozar JM, Constela M, García Sanz R, Gómez Veiga F et al (2007) Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Med Oral Patol Oral Cir Bucal 12, E336

    PubMed  Google Scholar 

  16. Weitzman R, Sauter N, Eriksen EF, Tarassoff PG, Lacerna LV, Dias R et al (2007) Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients—May 2006. Crit Rev Oncol Hematol 62(2):148–152

    Article  PubMed  Google Scholar 

  17. Cheng A, Mavrokokki A, Carter G, Stein B, Fazzalari NL, Wilson DF et al (2005) The dental implications of bisphosphonates and bone disease. Aust Dent J 50(4 Suppl 2):S4–S13

    Article  CAS  PubMed  Google Scholar 

  18. Lam DK, Sándor GK, Holmes HI, Evans AW, Clokie CM (2007) A review of bisphosphonate-associated osteonecrosis of the jaws and its management. J Can Dent Assoc 73(5):417–422

    PubMed  Google Scholar 

  19. Curi MM, Cossolin GS, Koga DH, Araújo SR, Feher O, dos Santos MO, Zardetto C (2007) Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases. J Oral Maxillofac Surg 65(2):349–355

    Article  PubMed  Google Scholar 

  20. Carter GD, Goss NA (2003) Bisphosphonates and avascular necrosis of the jaws. Aust Dent J 48(4):268

    CAS  PubMed  Google Scholar 

  21. Migliorati CA (2003) Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21(22):4253–4254

    Article  PubMed  Google Scholar 

  22. Pogrel MA (2004) Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 62(3):391–392

    Article  PubMed  Google Scholar 

  23. Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115–1117

    Article  PubMed  Google Scholar 

  24. Ruggiero SJ, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527–534

    Article  PubMed  Google Scholar 

  25. Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J et al (2011) Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. J Oral Maxillofac Surg 69(1):84–91

    Article  PubMed  Google Scholar 

  26. Badros A, Terpos E, Katodritou E, Goloubeva O, Kastritis E, Verrou E et al (2008) Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol 26(36):5904–5909

    Article  PubMed  Google Scholar 

  27. Montebugnoli L, Felicetti L, Gissi DB, Pizzigallo A, Pelliccioni GA, Marchetti C (2007) Bisphosphonate associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(4):473–477

    Article  PubMed  Google Scholar 

  28. Filleul O, Crompot E, Saussez S (2010) Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 136(8):1117–1124

    Article  CAS  PubMed  Google Scholar 

  29. O’Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D et al (2009) Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg 67(7):1363–1372

    Article  PubMed  Google Scholar 

  30. Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M et al (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23(6):826–836

    Article  CAS  PubMed  Google Scholar 

  31. Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E (2009) Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 20(2):331–336

    Article  PubMed  Google Scholar 

  32. Williamson RA (2010) Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 39(3):251–255

    Article  CAS  PubMed  Google Scholar 

  33. Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67(5 Suppl):85–95

    Article  PubMed  Google Scholar 

  34. Wutz A, Biederman E, Wanschitz F, Seemann R, Klug C, Baumann A et al (2008) Treatment results of bisphosphonate-related osteonecrosis of the jaws. Head Neck 30(9):1224–1230

    Article  Google Scholar 

  35. Markose G, Mackensie FR, Currie WJ, Hislop WS (2009) Bisphosphonate osteonecrosis: a protocol for surgical management. Br J Oral Maxillofac Surg 47(4):294–297

    Article  PubMed  Google Scholar 

  36. Stanton DC, Balasanian E (2009) Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. J Oral Maxillofac Surg 67(5):943–950

    Article  PubMed  Google Scholar 

  37. Wilde F, Heufelder M, Winter K, Hendricks J, Frerich B, Schramm A, Hemprich A (2011) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111(2):153–163

    Article  PubMed  Google Scholar 

  38. McLeod NM, Patel V, Kusanale A, Rogers SN, Brennan PA (2011) Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw. Br J Oral Maxillofac Surg 49(5):335–342

    Article  PubMed  Google Scholar 

  39. Franco S, Miccoli S, Limongelli L, Tempesta A, Favia G, Maiorano E, Favia G (2014) New dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari. Int J Dent 2014:935657

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  40. Spinelli G, Torresetti M, Lazzeri D, Zhang YX, Arcuri F, Agostini T, Grassetti L (2014) Microsurgical reconstruction after bisphosphonate-related osteonecrosis of the jaw: our experience with fibula free flap. J Craniofac Surg 25(3):788–792

    Article  PubMed  Google Scholar 

  41. Lee LW, Hsiao SH, Chen LK (2014) Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws. J Formos Med Assoc 113(3):166–172

    Article  PubMed  Google Scholar 

  42. Rupel K, Ottaviani G, Gobbo M, Contardo L, Tirelli G, Vescovi P, Di Lenarda R, Biasotto M (2014) A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol 50(11):1049–1057

    Article  CAS  PubMed  Google Scholar 

  43. Longo F, Guida A, Aversa C, Pavone E, Di Costanzo G, Ramaglia L, Ionna F (2014) Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent 2014:298945

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Zavalishina L, Karra N, Zaid WS, El-Hakim M (2014) Quality of life assessment in patients after mandibular resection and free fibula flap reconstruction. J Oral Maxillofac Surg 72(8):1616–1626

    Article  PubMed  Google Scholar 

  45. Vescovi P, Merigo E, Meleti M, Manfredi M, Fornaini C, Nammour S, Mergoni G, Sarraj A, Bagan JV (2014) Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw. Int J Dent 2014:107690

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  46. Carlson ER (2014) Management of antiresorptive osteonecrosis of the jaws with primary surgical resection. J Oral Maxillofac Surg 72(4):655–657

    Article  PubMed  Google Scholar 

  47. Sadiq Z, Sammut S, Lopes V (2014) Non-complex reconstructive techniques in the management of BRONJ: a case series of patient-related outcomes. Oral Maxillofac Surg 18(2):223–227

    Article  PubMed  Google Scholar 

  48. Soydan SS, Uckan S (2014) Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report. J Oral Maxillofac Surg 72(2):322–326

    Article  PubMed  Google Scholar 

  49. Stockmann P, Burger M, von Wilmowsky C, Ebker T, Lutz R, Bauersachs A, Nkenke E, Neukam FW, Wehrhan F (2014) The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw—results of a clinical case series with an average follow-up of 20 months. Clin Oral Investig 18(4):1299–1304

    PubMed  Google Scholar 

  50. Nomura T, Shibahara T, Uchiyama T, Yamamoto N, Shibui T, Yakushiji T, Watanabe A, Muramatsu K, Ogane S, Murayama M, Sekine R, Nakata E, Fujimoto Y (2013) Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic. Bull Tokyo Dent Coll 54(2):117–125

    Article  PubMed  Google Scholar 

  51. Holzinger D, Seemann R, Klug C, Ewers R, Millesi G, Baumann A, Wutzl A (2013) Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs). Oral Oncol 49(1):66–70

    Article  PubMed  Google Scholar 

  52. Hanasono MM, Militsakh ON, Richmon JD, Rosenthal EL, Wax MK (2013) Mandibulectomy and free flap reconstruction for bisphosphonate-related osteonecrosis of the jaws. JAMA Otolaryngol Head Neck Surg 139(11):1135–1142

    Article  PubMed  Google Scholar 

  53. Janovska Z, Mottl R, Slezak R (2015) Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 159(2):313–317

    PubMed  Google Scholar 

  54. Blus C, Szmukler-Moncler S, Giannelli G, Denotti G, Orrù G (2013) Use of ultrasonic bone surgery (piezosurgery) to surgically treat bisphosphonate-related osteonecrosis of the jaws (BRONJ). a case series report with at least 1 year of follow-up. Open Dent J 7:94–101

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Beninati F, Pruneti R, Ficarra G (2013) Bisphosphonate-related osteonecrosis of the jaws (Bronj). Med Oral Patol Oral Cir Bucal 18(5):e752–e758

    Article  PubMed Central  PubMed  Google Scholar 

  56. Freiberger JJ, Padilla-Burgos R, McGraw T, Suliman HB, Kraft KH, Stolp BW, Moon RE, Piantadosi CA (2012) What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. J Oral Maxillofac Surg 70(7):1573–1583

    Article  PubMed  Google Scholar 

  57. Graziani F, Vescovi P, Campisi G, Favia G, Gabriele M, Gaeta GM, Gennai S, Goia F, Miccoli M, Peluso F, Scoletta M, Solazzo L, Colella G (2012) Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases. J Oral Maxillofac Surg 70(11):2501–2507

    Article  PubMed  Google Scholar 

  58. Vescovi P, Manfredi M, Merigo E, Guidotti R, Meleti M, Pedrazzi G, Fornaini C, Bonanini M, Ferri T, Nammour S (2012) Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up. Photomed Laser Surg 30(1):5–13

    Article  PubMed  Google Scholar 

  59. Vescovi P, Merigo E, Meleti M, Manfredi M, Guidotti R, Nammour S (2012) Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med 41(3):214–221

    Article  CAS  PubMed  Google Scholar 

  60. Ferlito S, Puzzo S, Palermo F, Verzì P (2012) Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases. Br J Oral Maxillofac Surg 50(5):425–429

    Article  PubMed  Google Scholar 

  61. Andriani A, Petrucci MT, Caravita T, Montanaro M, Villivà N, Levi A, Siniscalchi A, Bongarzoni V, Pisani F, De Muro M, Coppetelli U, Avvisati G, Zullo A, Agrillo A, Gaglioti D (2012) Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom’s macroglobulinemia: a retrospective multicentric study. Blood Cancer J 2(3), e62

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  62. Jabbour Z, El-Hakim M, Mesbah-Ardakani P, Henderson JE, Albuquerque R Jr (2012) The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series. Int J Oral Maxillofac Surg 41(11):1404–1409

    Article  CAS  PubMed  Google Scholar 

  63. Anitua E, Begoña L, Orive G (2013) Treatment of hemimandibular paresthesia in a patient with bisphosphonate-related osteonecrosis of the jaw (BRONJ) by combining surgical resection and PRGF-Endoret. Br J Oral Maxillofac Surg 51(8):e272–e274

    Article  CAS  PubMed  Google Scholar 

  64. Hewson I, Syme D, Bruscino-Raiola F (2012) Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw. Aust Dent J 57(2):227–230

    Article  CAS  PubMed  Google Scholar 

  65. Cicciù M, Herford AS, Juodžbalys G, Stoffella E (2012) Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw. J Craniofac Surg 23(3):784–788

    Article  PubMed  Google Scholar 

  66. Mozzati M, Gallesio G, Arata V, Pol R, Scoletta M (2012) Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol 48(5):469–474

    Article  PubMed  Google Scholar 

  67. Gallego L, Junquera L, Pelaz A, Hernando J, Megías J (2012) The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla. Med Oral Patol Oral Cir Bucal 17(2):e236–e241

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  68. Voss PJ, Joshi Oshero J, Kovalova-Müller A, Veigel Merino EA, Sauerbier S, Al-Jamali J, Lemound J, Metzger MC, Schmelzeisen R (2012) Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients. J Craniomaxillofac Surg 40(8):719–725

    Article  PubMed  Google Scholar 

  69. Schubert M, Klatte I, Linek W, Müller B, Döring K, Eckelt U, Hemprich A, Berger U, Hendricks J (2012) The saxon bisphosphonate register - therapy and prevention of bisphosphonate-related osteonecrosis of the jaws. Oral Oncol 48(4):349–354

    Article  PubMed  Google Scholar 

  70. Martins MA, Martins MD, Lascala CA, Curi MM, Migliorati CA, Tenis CA, Marques MM (2012) Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study. Oral Oncol 48(1):79–84

    Article  PubMed  Google Scholar 

  71. Lemound J, Eckardt A, Kokemüller H, von See C, Voss PJ, Tavassol F, Rücker M, Rana M, Gellrich NC (2012) Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap. Clin Oral Investig 16(4):1143–1152

    Article  PubMed  Google Scholar 

  72. de Souza Faloni AP, Queiroz TP, Comelli Lia RC, Cerri PS, Margonar R, Rastelli AN, Marcantonio E (2011) Accurate approach in the treatment of oral bisphosphonate-related jaw osteonecrosis. J Craniofac Surg 22(6):2185–2190

    Article  PubMed  Google Scholar 

  73. Curi MM, Cossolin GS, Koga DH, Zardetto C, Christianini S, Feher O, Cardoso CL, dos Santos MO (2011) Bisphosphonate-related osteonecrosis of the jaws—an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J Oral Maxillofac Surg 69(9):2465–2472

    Article  PubMed  Google Scholar 

  74. Lee CY, Pien FD, Suzuki JB (2011) Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws. Implant Dent 20(5):331–336

    Article  PubMed  Google Scholar 

  75. Cella L, Oppici A, Arbasi M, Moretto M, Piepoli M, Vallisa D, Zangrandi A, Di Nunzio C, Cavanna L (2011) Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw. Head Face Med 7:16

    Article  PubMed Central  PubMed  Google Scholar 

  76. Atalay B, Yalcin S, Emes Y, Aktas I, Aybar B, Issever H, Mandel NM, Cetin O, Oncu B (2011) Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci 26(6):815–823

    Article  PubMed  Google Scholar 

  77. Wilde F, Hendricks J, Riese C, Pausch NC, Schramm A, Heufelder M (2011) Bone regeneration without bone grafting after resection of a segment of the mandible to treat bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 69(10):2657–2662

    Article  PubMed  Google Scholar 

  78. Eckardt AM, Lemound J, Lindhorst D, Rana M, Gellrich NC (2011) Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem. Anticancer Res 31(6):2313–2318

    CAS  PubMed  Google Scholar 

  79. Bedogni A, Saia G, Bettini G, Tronchet A, Totola A, Bedogni G, Ferronato G, Nocini PF, Blandamura S (2011) Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis. Oral Oncol 47(5):420–424

    Article  PubMed  Google Scholar 

  80. Hoefert S, Eufinger H (2011) Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 69(2):362–380

    Article  PubMed  Google Scholar 

  81. Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P (2011) Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis. Int J Oral Maxillofac Surg 40(3):277–284

    Article  CAS  PubMed  Google Scholar 

  82. Mücke T, Koschinski J, Deppe H, Wagenpfeil S, Pautke C, Mitchell DA, Wolff KD, Hölzle F (2011) Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res Clin Oncol 137(5):907–913

    Article  PubMed  CAS  Google Scholar 

  83. Scoletta M, Arduino PG, Dalmasso P, Broccoletti R, Mozzati M (2010) Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(1):46–53

    Article  PubMed  Google Scholar 

  84. Rugani P, Acham S, Truschnegg A, Obermayer-Pietsch B, Jakse N (2010) Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(6):e1–e6

    Article  PubMed  Google Scholar 

  85. Sacco R, Sacco G, Acocella A, Sale S, Sacco N, Baldoni E (2011) A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis. J Appl Oral Sci 19(4):293–300

    PubMed Central  CAS  PubMed  Google Scholar 

  86. Wutzl A, Pohl S, Sulzbacher I, Seemann R, Lauer G, Ewers R, Drach J, Klug C (2012) Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws. Head Neck 34(2):194–200

    Article  PubMed  Google Scholar 

  87. Stockmann P, Vairaktaris E, Wehrhan F, Seiss M, Schwarz S, Spriewald B, Neukam FW, Nkenke E (2010) Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Support Care Cancer 18(4):449–460

    Article  PubMed  Google Scholar 

  88. Chiu CT, Chiang WF, Chuang CY, Chang SW (2010) Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw—a serial case analysis. J Oral Maxillofac Surg 68(5):1055–1063

    Article  PubMed  Google Scholar 

  89. Favia G, Pilolli GP, Maiorano E (2009) Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients. J Rheumatol 36(12):2780–2787

    Article  PubMed  Google Scholar 

  90. Junquera L, Gallego L, Cuesta P, Pelaz A, de Vicente JC (2009) Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases. Am J Otolaryngol 30(6):390–395

    Article  CAS  PubMed  Google Scholar 

  91. Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, Hughes PJ, Michalowicz BS, Leach JW, Swenson KK, Swift JQ, Adkinson C, Basi DL (2009) Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg 67(9):1904–1913

    Article  PubMed  Google Scholar 

  92. Cetiner S, Sucak GT, Kahraman SA, Aki SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R (2009) Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab 27(4):435–443

    Article  CAS  PubMed  Google Scholar 

  93. Alons K, Kuijpers SC, de Jong E, van Merkesteyn JP (2009) Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107(2):e1–e7

    Article  PubMed  Google Scholar 

  94. Saussez S, Javadian R, Hupin C, Magremanne M, Chantrain G, Loeb I, Decaestecker C (2009) Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series. Laryngoscope 119(2):323–329

    Article  CAS  PubMed  Google Scholar 

  95. Engroff SL, Coletti D (2008) Bisphosphonate related osteonecrosis of the palate: report of a case managed with free tissue transfer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105(5):580–582

    Article  PubMed  Google Scholar 

  96. Aarabi S, Draper L, Grayson B, Gurtner GC (2008) Bisphosphonate-associated osteonecrosis of the jaw: successful treatment at 2-year follow-up. Plast Reconstr Surg 122(2):57e–59e

    Article  PubMed  Google Scholar 

  97. Adornato MC, Morcos I, Rozanski J (2007) The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 138(7):971–977

    Article  PubMed  Google Scholar 

  98. Diego R, D’Orto O, Pagani D, Agazzi A, Marzano U, Derada Troletti G, Fontanella W, Pignataro L (2007) Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(3):e1–e5

    Article  PubMed  Google Scholar 

  99. Borgioli A, Duvina M, Brancato L, Viviani C, Brandi ML, Tonelli P (2007) Bisphosphonate-related osteonecrosis of the jaw: the Florence experience. Clin Cases Miner Bone Metab 4(1):48–52

    PubMed Central  PubMed  Google Scholar 

  100. Lee CY, David T, Nishime M (2007) Use of platelet-rich plasma in the management of oral bisphosphonate-associated osteonecrosis of the jaw: a report of 2 cases. J Oral Implantol 33(6):371–382

    Article  PubMed  Google Scholar 

  101. Bagán J, Blade J, Cozar JM et al (2007) Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Med Oral Patol Oral Cir Bucal 12(4):E336–E340

    PubMed  Google Scholar 

  102. Hansen T, Kunkel M, Weber A et al (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates—Histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35(3):155–160

    Article  PubMed  Google Scholar 

  103. Seth R, Futran ND, Alam DS et al (2010) Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonate-related osteonecrosis of the jaws. Laryngoscope 120(11):2165–2171

    Article  PubMed  Google Scholar 

  104. Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH (1998) Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin Orthop Relat Res. (355 Suppl):S314-35

  105. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR (1998) Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85(6):638–646

    Article  CAS  PubMed  Google Scholar 

  106. Dugrillon A, Eichler H, Kern S, Klüter H (2002) Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 31(6):615–619

    Article  CAS  PubMed  Google Scholar 

  107. Oyama T, Nishimoto S, Tsugawa T, Shimizu F (2004) Efficacy of platelet-rich plasma in alveolar bone grafting. J Oral Maxillofac Surg 62(5):555–558

    Article  PubMed  Google Scholar 

  108. Schilephake H (2002) Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31(5):469–484

    Article  CAS  PubMed  Google Scholar 

  109. Bhanot S, Alex JC (2002) Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 18(1):27–33

    Article  PubMed  Google Scholar 

  110. Schmitz JP, Hollinger JO (2001) The biology of platelet-rich plasma. J Oral Maxillofac Surg 59(9):1119–1121

    Article  CAS  PubMed  Google Scholar 

  111. Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62(4):489–496

    Article  PubMed  Google Scholar 

  112. Freymiller EG, Aghaloo TL (2004) Platelet-rich plasma: ready or not? J Oral Maxillofac Surg 62(4):484–488

    Article  PubMed  Google Scholar 

  113. Freymiller EG (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62:1046

    Article  PubMed  Google Scholar 

  114. Man D, Plosker H, Winland-Brown JE (2001) The use of autólogos platelet-rich plasma (plasma gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 107(1):229–237

    Article  CAS  PubMed  Google Scholar 

  115. Thorn JJ, Sorensen H, Weis-Fogh U, Andersen M (2004) Autologous fibrin glue with growth factors in reconstructive maxillofacial surgery. Int J Oral Maxillofac Surg 33(1):95–100

    Article  CAS  PubMed  Google Scholar 

  116. Arora NS, Ramanayake T, Ren YF, Romanos GE (2009) Platelet-rich plasma: a literature review. Implant Dent 18(4):303–310

    Article  PubMed  Google Scholar 

  117. Lopez-Vidriero E, Goulding KA, Simon DA, Sanchez M, Johnson DH (2010) The use of plateletrich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy 26(2):269–278

    Article  PubMed  Google Scholar 

  118. Plachokova AS, Nikolidakis D, Mulder J, Jansen JA, Creugers NH (2008) Effect of plateletrich plasma on bone regeneration in dentistry: a systematic review. Clin Oral Implants Res 19(6):539–545

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcelo Salles Munerato.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Financial source

São Paulo Research Foundation (FAPESP – 2014/10693-6).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silva, L.F., Curra, C., Munerato, M.S. et al. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review. Oral Maxillofac Surg 20, 9–17 (2016). https://doi.org/10.1007/s10006-015-0538-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10006-015-0538-x

Keywords

Navigation